EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 4.0

Epidemiology and Real-World Outcomes in Patients with Human Epidermal Growth Factor Receptor 2 (HER2)-Mutant Non-small Cell Lung Cancer by Region: A Targeted Literature Review

Koichi Goto, Hidetoshi Hayashi, Sonia S Maruti, Heiko Zettl, Lalith Mittal, Smit Pathak, Xiuning Le

Targeted Oncology · 2026-05 · 21 (3) · 337-356

DOI: 10.1007/s11523-026-01213-4 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Targeted Oncology, online erschienen am 06.05.2026. Verfasst von Koichi Goto und 6 weiteren Autor:innen. Beteiligte Einrichtung: National Cancer Center Hospital East, 6-5-1 Kashiwanoha, Kashiwa, Chiba, 277-8577, Japan. kgoto@east.ncc.go.jp. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Erb-b2 Receptor Tyrosine Kinases. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 106 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Boehringer Ingelheim.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Non-Small-Cell LungLung NeoplasmsErb-b2 Receptor Tyrosine KinasesHumansMutationFemale

Substanzen

Erb-b2 Receptor Tyrosine KinasesERBB2 protein, human

Autor:innen und Institutionen

  • National Cancer Center Hospital East, 6-5-1 Kashiwanoha, Kashiwa, Chiba, 277-8577, Japan. kgoto@east.ncc.go.jp.
  • Kindai University Hospital, Sakai, Japan.
  • Kindai Hospital Global Alliance Research Center, Sakai, Japan.
  • Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT, USA.
  • Boehringer Ingelheim International GmbH, Ingelheim am Rhein, Germany.
  • Evidera Health Economics & Market Access, Thermo Fisher Scientific, Bengaluru, Karnataka, India.

Förderung

  • Boehringer Ingelheim

Zitieren

APA

Goto, K., Hayashi, H., Maruti, S. S., Zettl, H., Mittal, L., Pathak, S., & Le, X. (2026). Epidemiology and Real-World Outcomes in Patients with Human Epidermal Growth Factor Receptor 2 (HER2)-Mutant Non-small Cell Lung Cancer by Region: A Targeted Literature Review. Targeted Oncology, 21(3), 337-356. https://doi.org/10.1007/s11523-026-01213-4

Vancouver

Goto K, Hayashi H, Maruti SS, Zettl H, Mittal L, Pathak S, et al. Epidemiology and Real-World Outcomes in Patients with Human Epidermal Growth Factor Receptor 2 (HER2)-Mutant Non-small Cell Lung Cancer by Region: A Targeted Literature Review. Targeted Oncology. 2026;21(3):337-356. doi:10.1007/s11523-026-01213-4

BibTeX
@article{Goto2026,
  author = {Goto, Koichi and Hayashi, Hidetoshi and Maruti, Sonia S and Zettl, Heiko and Mittal, Lalith and Pathak, Smit and Le, Xiuning},
  title = {Epidemiology and Real-World Outcomes in Patients with Human Epidermal Growth Factor Receptor 2 (HER2)-Mutant Non-small Cell Lung Cancer by Region: A Targeted Literature Review},
  journal = {Targeted Oncology},
  year = {2026},
  volume = {21},
  number = {3},
  pages = {337--356},
  doi = {10.1007/s11523-026-01213-4}
}
Kostenlos starten →